BE831691A - Preparation pour le traitement de maladies infectieuses, procede pour son obtention et son utilisation - Google Patents

Preparation pour le traitement de maladies infectieuses, procede pour son obtention et son utilisation

Info

Publication number
BE831691A
BE831691A BE158575A BE158575A BE831691A BE 831691 A BE831691 A BE 831691A BE 158575 A BE158575 A BE 158575A BE 158575 A BE158575 A BE 158575A BE 831691 A BE831691 A BE 831691A
Authority
BE
Belgium
Prior art keywords
obtaining
preparation
treatment
infectious diseases
infectious
Prior art date
Application number
BE158575A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742437166 external-priority patent/DE2437166C3/de
Application filed filed Critical
Publication of BE831691A publication Critical patent/BE831691A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
BE158575A 1974-08-01 1975-07-24 Preparation pour le traitement de maladies infectieuses, procede pour son obtention et son utilisation BE831691A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742437166 DE2437166C3 (de) 1974-08-01 Arzneimittel gegen interferonsensible, viralbedingte Infektionskrankheiten

Publications (1)

Publication Number Publication Date
BE831691A true BE831691A (fr) 1975-11-17

Family

ID=5922207

Family Applications (1)

Application Number Title Priority Date Filing Date
BE158575A BE831691A (fr) 1974-08-01 1975-07-24 Preparation pour le traitement de maladies infectieuses, procede pour son obtention et son utilisation

Country Status (13)

Country Link
US (1) US4053582A (cs)
JP (1) JPS5141420A (cs)
AT (1) AT343797B (cs)
BE (1) BE831691A (cs)
CA (1) CA1057195A (cs)
CH (1) CH614627A5 (cs)
DK (1) DK141835C (cs)
ES (1) ES439966A1 (cs)
FR (1) FR2280390A1 (cs)
GB (1) GB1517540A (cs)
NL (1) NL7509136A (cs)
SE (1) SE7508565L (cs)
ZA (1) ZA754725B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US4309416A (en) * 1979-09-20 1982-01-05 Research Corporation Vaccines from taxonomically similar organisms
EP0037441B1 (en) * 1980-03-10 1984-05-09 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and anti-tumor agent, process for production thereof and microorganism used therein
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
EP0080032A3 (en) * 1981-11-20 1985-11-13 Enzo Biochem, Inc. Pharmaceutical preparation for treating herpetic lesions
US4497795A (en) * 1982-12-13 1985-02-05 The Texas A&M University System Method of regulating appetite and efficiency of food utilization employing interferon
US4820515A (en) * 1982-12-13 1989-04-11 Texas A&M University System Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
US5910304A (en) * 1982-12-13 1999-06-08 Texas A&M University System Low-dose oral administration of interferons
HU197517B (en) * 1984-07-30 1989-04-28 Laszlo Csatary Process for production of terapeutical composition applicable against virus infection
US4820514A (en) * 1985-12-30 1989-04-11 Texas A&M University System Low dosage of interferon to enhance vaccine efficiency
CA1320905C (en) * 1986-11-06 1993-08-03 Joseph M. Cummins Treatment of immuno-resistant disease
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
US4758426A (en) * 1987-06-11 1988-07-19 Ramsdell Bruce V Therapeutic toilet solution and method of dispersion
US5017371A (en) * 1988-01-06 1991-05-21 Amarillo Cell Culture Company, Incorporated Method for reducing side effects of cancer therapy
US4867975A (en) * 1988-01-27 1989-09-19 University Of Delaware Live attenuated temperature-sensitive avian infectious bronchitis virus vaccines and preparation and use thereof
US5124148A (en) * 1988-04-27 1992-06-23 United Cancer Research Institute Method for treating viral diseases with attenuated virus
US5215745A (en) * 1988-04-27 1993-06-01 United Cancer Research Institute Method for treating viral diseases with attenuated virus
DK0696326T5 (da) 1993-04-30 2003-07-14 Wellstat Biologics Corp Anvendelse af NDV til fremstilling af et medikament til behandling af cancer
FR2707458B1 (fr) * 1993-07-12 1995-10-06 Sagal Ingrédients alimentaires obtenus par fermentation avec S. Boulardii et aliments les contenant.
US6140107A (en) * 1996-09-25 2000-10-31 Viva America Marketing, Inc. Organometallic-metabolizing yeast
US20030138454A1 (en) * 1997-06-09 2003-07-24 Oxxon Pharmaccines, Ltd. Vaccination method
GB9711957D0 (en) * 1997-06-09 1997-08-06 Isis Innovation Methods and reagents for vaccination
GB0118532D0 (en) * 2001-07-30 2001-09-19 Isis Innovation Materials and methods relating to improved vaccination strategies
GB2382578A (en) * 2001-11-30 2003-06-04 Isis Innovation Fowlpox-based vaccine
CA2467486A1 (en) * 2001-11-30 2003-06-12 Isis Innovation Limited Vaccine
US20050175627A1 (en) * 2003-09-24 2005-08-11 Oxxon Therapeutics Ltd. HIV pharmaccines
DE10349115A1 (de) * 2003-10-22 2005-06-16 Biosyn Arzneimittel Gmbh Kombinationspräparat zur Behandlung der Sepsis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429965A (en) * 1966-08-01 1969-02-25 Sterling Drug Inc Avian pox virus vaccine and process of preparing same

Also Published As

Publication number Publication date
US4053582A (en) 1977-10-11
CH614627A5 (cs) 1979-12-14
JPS5141420A (cs) 1976-04-07
SE7508565L (sv) 1976-02-02
FR2280390B1 (cs) 1980-04-11
ATA598975A (de) 1977-10-15
DE2437166A1 (de) 1976-02-19
DE2437166B2 (de) 1977-01-27
GB1517540A (en) 1978-07-12
ZA754725B (en) 1976-06-30
CA1057195A (en) 1979-06-26
DK141835B (da) 1980-06-30
FR2280390A1 (fr) 1976-02-27
AT343797B (de) 1978-06-12
NL7509136A (nl) 1976-02-03
DK141835C (da) 1980-11-10
ES439966A1 (es) 1977-03-01
DK347775A (da) 1976-02-02

Similar Documents

Publication Publication Date Title
BE831691A (fr) Preparation pour le traitement de maladies infectieuses, procede pour son obtention et son utilisation
FR2293449A1 (fr) Polyurethannes anioniques, leur procede de preparation et leur utilisation
FR2286134A1 (fr) Nouvelles urethannoxazolidines, et leur procede de preparation
FR2286154A1 (fr) Procede de preparation de polyurethannes
BE831843A (fr) Procede de preparation de polyurees
BE837242A (fr) Plasma sanguin stable, son procede de preparation et ses applications
BE827470A (fr) Procede de traitement de membranes
BE834064A (fr) Procede de preparation de carboxamides de oxo-1,2-benzothiazine-1, 1-dioxydes
FR2276276A1 (fr) Procede de preparation de platre
BE834443A (fr) Procede de preparation de cyclohexane-diones-1,3 et d'alkyl-6-dihydro-3,4 -pyranones-2
FR2280386A1 (fr) 7-methoxy-6-thia-tetracyclines et leur procede de preparation
BE817113A (fr) Procede de preparation de cyclo-alkenes
BE844993A (fr) Procede de traitement de la mitraille
FR2277060A1 (fr) Procede de preparation de monoalcenylbenzenes
BE830814A (fr) N-alkyl-iminoalanes oligomeres et leur procede de preparation
BE837051A (fr) Procede de preparation de pinacoline
BE831633A (fr) Procede de preparation de polyurees
BE832364A (fr) 17 alpha-hydroxy-1,3,5(10), 15-oestratetraenes et leur procede de preparation
FR2296645A1 (fr) 3a, 5a-cyclo-6b-alkoxy-25-hydroxycholest-22-yne et son procede de preparation
BE833328A (fr) Procede de preparation de 6-chloro-2-chloro-methyl-4-phenylquinazoline-3-oxyde, et intermediaires appropries
FR2353516A2 (fr) Procede de preparation de fluoronitrobenzenes
BE826139A (fr) 11beta-fluoro-androstenes et leur procede de preparation
BE827712A (fr) Colorants azoiques leur procede de preparation et leur utilisation
BE824179A (fr) Bis-dihalogeno-s-triazinyl-urees et leur procede de preparation
BE825499A (fr) Procede de preparation de la cis-vincamine